---
layout: post
title:  "Factor Xa-aptamer"
date:   2024-04-16 00:00:00
author: Bichun Wu, Jiaxin Zhao
categories: Aptamer
---
<html>
<head>
  <title>横向排列的点击按钮</title>
  <style>
    /* 按钮容器样式 */
    .button-container {
      display: flex;
      justify-content: left;
      align-items: center;
      height: 50px;
    }
    /* 按钮样式 */
    .button {
      display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #ffffff;
      color: #520049;
      text-decoration: none;
      border: 1px solid #520049;
      border-radius: 5px;
    }
    /* 鼠标悬停样式 */
    .button:hover {
      background-color: #c9c5c5;
      cursor: pointer;
    }
  </style>
</head>
<!--body>
  <p style="font-size: 16px">Click the buttons to navigate to different sections:</p>
  <div class="button-container">
    <a class="button" style="color:#520049" href="#timeline">Timeline</a>
    <a class="button" style="color:#520049" href="#description">Description</a>
    <a class="button" style="color:#520049" href="#SELEX">SELEX</a>
    <a class="button" style="color:#520049" href="#structure">Structure</a>
    <a class="button" style="color:#520049" href="#ligand-recognition">Ligand recognition
    <a class="button" style="color:#520049" href="#references">References</a>
   </a>
  </div>
</body-->
</html>

<html lang="zh-cn">
<head>
<meta charset="utf-8"> 
<style>
  .header_box {
     display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #c9c5c5;
      border-radius: 5px;
      width:225px;
	    height:50px;
  }
  .header_boxx1 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:115px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx2 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:140px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx3 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:85px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx4 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:120px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx5 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:215px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .header_boxx6 {
    display: block;
      padding: 10px;
      font-size:24px;
      margin-right: 10px;
      text-align: left;
      background-color: #ffffff;
      text-decoration: none;
      border-radius: 1px;
      width:135px;
	    height:50px;
      border-width: 1px 1px 2px 1px;
      border-style: solid solid solid solid;
      border-color:#ffffff #ffffff #ccc #ffffff;
  }
  .blowheader_box{
    display: block;
      padding: 10px;
      font-size:18px;
      margin-right: 10px;
      text-align: center;
      background-color: #efefef;
      color: #000000;
      text-decoration: none;
      border: 1px solid #ffffff;
      border-radius: 5px;
      width:170px;
	    height:40px;
  }
  .box_style{
    background: #ffffff;
  }
  blockquote {
  margin: 0 0 0px;
  }
</style>
</head>
<p><br /></p>


<p class="header_boxx1" id="timeline">Timeline</p>
<div class="timeline">
  <div class="entry">
    <div class="title">
      <h3><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820749/" target="_blank" style="color:#520049">2009</a></h3>
    </div>
    <div class="body">
      <p>An RNA aptamer (RNA11F7t), which was selected from a combinatorial library for its ability to bind factor Xa, is characterized in our study<sup>[<a href="#ref1" style="color:#520049">1</a>]</sup></p>
    </div>
  </div>
  <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/29863725/" target="_blank" style="color:#520049">2018</a></h3>
    </div>
    <div class="body">
      <p>They solved X-ray crystal structures of the aptamer bound to factor Xa (FXa)<sup>[<a href="#ref3" style="color:#520049">3</a>]</sup></p>
    </div>
  </div>
    <div class="entry">
    <div class="title">
      <h3><a href="https://pubmed.ncbi.nlm.nih.gov/35021888/" target="_blank" style="color:#520049">2022</a></h3>
    </div>
    <div class="body">
      <p>The combination of factor X/Xa aptamer and UFH has significantly improved anticoagulant properties compared to UFH alone and underscores the potential of RNA aptamers to improve medical management of acute care patients requiring potent yet rapidly reversible anticoagulation<sup>[<a href="#ref4" style="color:#520049">4</a>]</sup></p>
    </div>
  </div>
</div>


         
<font ><p class="header_boxx2" id="description">Description</p></font>
<font >In 2009, Buddai, Sai K et al. present the characterization of an RNA aptamer (RNA11f7t) developed by cyclical screening of a combinatorial library against factor Xa. They show that potent inhibition of thrombin formation catalyzed by prothrombinase unexpectedly results from the ability of RNA11f7t to bind factor Xa with high affinity and inhibit its interaction with factor Va on the membrane surface. In 2018, Gunaratne, Ruwan et al. solved X-ray crystal structures of the aptamer bound to factor Xa (FXa). They demonstrate that combinations of 11F7t and catalytic-site FXa inhibitors enhance anticoagulation in purified reaction mixtures and plasma<sup>[<a href="#ref1" style="color:#520049">1</a></sup><sup>,<a href="#ref2" style="color:#520049">2</a></sup><sup>]</sup>.<br></font>
<p><br /></p> <br>

<p class="header_boxx3" id="SELEX">SELEX</p>
<p>They present the characterization of an RNA aptamer (RNA11f7t) developed by cyclical screening of a combinatorial library against factor Xa. They show that potent inhibition of thrombin formation catalyzed by prothrombinase unexpectedly results from the ability of RNA11f7t to bind factor Xa with high affinity and inhibit its interaction with factor Va on the membrane surface.After 11 rounds of selection, the products were digested with EcoR1 and BamH1 (New England Biolabs) and directionally cloned into pUC19 linearized with the same enzymes. Individual clones were sequenced, and clonal RNA transcripts were analyzed in filter binding assays. The lead molecule was systematically shortened to obtain a truncated version (RNA11F7t) that retained binding activity<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.<br>
Detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/SELEX" target="_blank" style="color:#520049"><b><i>SELEX</i></b></a> page.</p>
<br> <br>    



<p class="header_boxx4" id="Structure">Structure</p>
<p class="blowheader_box">2D representation</p>
<font><p>FXa aptamer, 11F7t, mFold predicted structure, 36 nts in length.Here we used ribodraw to complete the figure, through the 3D structure information. 11F7t was the aptamer sequence mainly studied in SELEX article<sup>[<a href="#ref2" style="color:#520049">2</a></sup><sup>,<a href="#ref4" style="color:#520049">4</a></sup><sup>]</sup>.</p></font>
<font><p>5'-GAGAGCCCCAGCGAGAUAAUACUUGGCCCCGCUCUU-3'</p></font>
<img src="/images/2D/Xa-aptamer_2D.svg" alt="drawing" style="width:800px;display:block;margin:0 auto;border-radius:0;" class="img-responsive">
<div style="display: flex; justify-content: center;">   
</div>
<br>


<p class="blowheader_box">3D visualisation</p>             
<font >Gunaratne, Ruwan et al. able to crystallize and solve the structure of a ternary complex between GD-FXaS195A, 11F7t, and rivaroxaban bound to the active site of the proteinase at 2.25 Å resolution. The PDB ID of this structure is 5VOF<sup>[<a href="#ref1" style="color:#520049">1</a></sup><sup>]</sup>. Additional available structures that have been solved and detailed information are accessible on <a href="{{ site.url }}{{ site.baseurl }}/structures" target="_blank" style="color:#520049"><b><i>Structures</i></b></a> page.</font>
<div ><font ><p style="text-align:right;margin-bottom: 0px;">(Clicking the "Settings/Controls info" to turn Spin off)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></font>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/3D/Xa-aptamer_3D1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <html lang="en">
    <head>
      <meta charset="utf-8" />
      <meta name="viewport" content="width=device-width, user-scalable=no, minimum-scale=1.0, maximum-scale=1.0">
      <meta http-equiv="X-UA-Compatible" content="IE=edge">
      <title>PDBe Molstar</title>
      <!-- Molstar CSS & JS -->
      <link rel="stylesheet" type="text/css" href="https://www.ebi.ac.uk/pdbe/pdb-component-library/css/pdbe-molstar-1.2.1.css">
      <script src="/js/mol/ro_pdbe-molstar-plugin-1.2.1.js"></script>
        <style>
          * {
              margin: 0;
              padding: 0;
              box-sizing: border-box;
          }
          .msp-plugin ::-webkit-scrollbar-thumb {
              background-color: #474748  !important;
          }
          .viewerSection1 {
            padding-top: 0px;
          }
          .controlsSection1 {
            width: 300px;
              display: flex;
              float:left;
              padding: 0px 0 0 0;
              height:25px;
            }
            .controlBox1 {
              border: 0px solid lightgray;
              padding: 0px;
              margin-bottom: 0px;
            }
          #myViewer1{
            float:left;
            width:500px;
            height: 500px;
            position:relative;
          }
        </style>
    </head>
    <body onload="customize()">
        <div class="controlsSection1">
            <button onclick="
              var selectSections1 = [
                {
  struct_asym_id: 'A',    
  start_residue_number:1, 
  end_residue_number:7, 
  color:{r:0,g:201,b:22}
},
{
  struct_asym_id: 'A', 
  start_residue_number:8, 
  end_residue_number:8, 
  color:{r:255,g:192,b:203}
},
{
  struct_asym_id: 'A', 
  start_residue_number:9, 
  end_residue_number:9, 
  color:{r:0,g:201,b:22}
},
{
  struct_asym_id: 'A', 
  start_residue_number:10, 
  end_residue_number:10, 
  color:{r:255,g:192,b:203}
},
{
  struct_asym_id: 'A', 
  start_residue_number:11, 
  end_residue_number:27, 
  color:{r:0,g:201,b:22}
},
{
  struct_asym_id: 'A', 
  start_residue_number:28, 
  end_residue_number:28, 
  color:{r:255,g:192,b:203}
},
{
  struct_asym_id: 'A', 
  start_residue_number:29, 
  end_residue_number:29 
  color:{r:0,g:201,b:22}
},
{
  struct_asym_id: 'A', 
  start_residue_number:30, 
  end_residue_number:30 
  color:{r:255,g:192,b:203}
},
{
  struct_asym_id: 'H', 
  start_residue_number:16, 
  end_residue_number:301 
  color:{r:9,g:254,b:254}
},
{
  struct_asym_id: 'L', 
  start_residue_number:88, 
  end_residue_number:136 
  color:{r:50,g:205,b:50}
}
              ]
            viewerInstance1.visual.select({ data: selectSections1, nonSelectedColor: {r:255,g:255,b:255}})" style="float:right;height:25px;width: 120px;">Color Selection</button><br><br>
          <button button style="float: left;height:25px;width: 120px;" onclick="viewerInstance1.visual.clearSelection()">Clear Selection</button><br><br>
      </div>
    <div class="viewerSection1">
    <!-- Molstar container -->
      <div id="myViewer1"></div>
    </div>
    <script>
      var viewerInstance1 = new PDBeMolstarPlugin();
      var options1 = {
        customData:{
        url:'/pdbfiles/5vof-3D.pdb',
        format: 'pdb'},
        expanded: false,
        hideControls: true,
        bgColor: {r:255, g:255, b:255},
        }
      var viewerContainer1 = document.getElementById('myViewer1');
      viewerInstance1.render(viewerContainer1, options1);
  window.addEventListener('load', function() {
    var colorSelectionButton1 = document.querySelector('.controlsSection1 button');
    colorSelectionButton1.click();
  });
</script>
</body>
</html></td>
</tr></table><br>
</div>


<p class="blowheader_box">Binding pocket</p>             
<font >Left: Surface representation of the binding pocket of the aptamer generated from PDB ID: 5VOF. FXaS195A (shown in vacuumm electrostatics), blue is positive charge, red is negative charge. Right: The hydrogen bonds of binding sites of the aptamer bound with FXaS195A.</font>
<br><br>
  <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
  <td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Xa-aptamer_binding_pocket1.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  <td style="text-align:center;padding-bottom: 0px;padding-right: 0px;padding-top: 0px;padding-right: 0px">
  <img src="/images/Binding_pocket/Xa-aptamer_binding_pocket2.svg" alt="drawing" style="width:500px;margin-top: 0px;margin-bottom: 0px;" >
  </td>
  </tr>
  </table>
  <br><br>





<font ><p class="header_boxx5" id="ligand-recognition">Ligand information</p></font>  
<p class="blowheader_box">SELEX ligand</p>
<font>The dependence of the initial rate of thrombin formation on increasing concentrations of factor Va at different fixed concentrations of aptamer were analyzed by assuming mutually exclusive binding interactions in rapid equilibrium between Xa and factor Va versus Xa and aptamer. Analysis according to the cubic equation of reference yielded fitted values for Kd for the membrane-dependent interaction between Xa and Va (Kd Xa,Va), mol of Va bound/mol of Xa at saturation, Kd for aptamer binding to Xa (Kd RNA, Xa), mol of aptamer bound/mol of Xa at saturation, rate at zero Va, and rate at infinite Va<sup>[<a href="#ref2" style="color:#520049">2</a>]</sup>.</font >
<div style="display: flex; justify-content: center;">
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Name</th>
        <!--th onclick="sortTable(0)">Sequence</th-->
        <th onclick="sortTable(0)">Ligand</th>
        <th onclick="sortTable(0)">Affinity</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0">Factor Xa-aptamer</td>
        <!--td name="td1">UGGGGUAUCGCCAAGCGGUAAGGCACCGGAUUCUGAUUCCGGCAUUCCGAGGUUCGAAUCCUCGUACCCCAGCCA</td-->
        <td name="td3">DesGla-XaS195A</td>
        <td name="td4">1.1 ± 0.2nM</td>
      </tr>
	  </tbody>
  </table>
  </div>
<br>

<p class="blowheader_box">Structure ligand</p>
<font><p>Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.-----from drugbank</p></font>
<br>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">PubChem CID</th>
        <th onclick="sortTable(1)">Molecular Formula</th>
        <th onclick="sortTable(2)">MW</th>
        <th onclick="sortTable(3)">CAS</th>
        <th onclick="sortTable(4)">Solubility</th>
        <th onclick="sortTable(5)">Drugbank ID</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/9875401" target="_blank" style="color:#520049"><b>9875401</b> </a></td>
        <td name="td1">C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>5</sub>S</td>
        <td name="td2">435.9 g/mol</td>
        <td name="td3">366789-02-8</td>
        <td name="td4">50 mg/ml(in DMSO)</td>
        <td name="td5"><a href="https://go.drugbank.com/drugs/DB06228" target="_blank" style="color:#520049"><b>DB06228</b> </a></td>
      </tr>
	  </tbody>
  </table>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/Xa_stru_ligand1.svg" alt="drawing" style="width:400px"  px="" /></td>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/Xa_stru_ligand2.svg" alt="drawing" style="width:400px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;">
</div>

<font><p>Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.-----from Uniprot</p></font>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(0)">Uniprot ID</th>
        <th onclick="sortTable(1)">Pfam</th>
        <th onclick="sortTable(2)">MW</th>
        <th onclick="sortTable(3)">Amino acids sequences</th>
        <th onclick="sortTable(4)">PDB ID</th>
        <th onclick="sortTable(5)">GenBank</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td0"><a href="https://www.uniprot.org/uniprotkb/P00742/entry" target="_blank" style="color:#520049"><b>P00742</b></a></td>
        <td name="td1"><a href="https://www.ebi.ac.uk/interpro/entry/pirsf/PIRSF001143/" target="_blank" style="color:#520049"><b>PIRSF001143</b></a></td>
        <td name="td2">28.51 kDa</td>
        <td name="td3">IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK</td>
        <td name="td4"><a href="https://www.rcsb.org/structure/1FAX" target="_blank" style="color:#520049"><b>1FAX</b></a></td>
        <td name="td5"><a href="https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?lvl=0&id=9606" target="_blank" style="color:#520049"><b>9606</b> </a></td>
      </tr>
	  </tbody>
  </table>
 <table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;"><tr>
<td style="text-align:center;padding-bottom: 0px;padding-left: 0px;padding-top: 0px;padding-right: 0px"><img src="/images/Structure_ligand/Xa_stru_ligand3.svg" alt="drawing" style="width:800px"  px="" /></td>
</tr>
</table>
<div style="display: flex; justify-content: center;">
  </div>


<p class="blowheader_box">Similar compound</p>
<font><p>We used the Dail server website to compare the structural similarities of ligand proteins, and selected the previous information with high similarity for presentation.The Dali server is a network service for comparing protein structures in 3D. Dali compares them against those in the Protein Data Bank (PDB).</p></font>
<table class="table table-bordered" style="table-layout:fixed;width:1000px;margin-left:auto;margin-right:auto;" >
  <thead>
      <tr>
        <th onclick="sortTable(1)">PDB</th>
        <th onclick="sortTable(2)">Z-score</th>
        <th onclick="sortTable(3)">RMSD</th>
        <th onclick="sortTable(4)">Description</th>
      </tr>
  </thead>
    <tbody>
      <tr>
        <td name="td1">5VOF-H</td>
        <td name="td2">48.5</td>
        <td name="td3">0</td>
        <td name="td4">Coagulation factor x</td>
      </tr>
      <tr>
        <td name="td1">5VOE-H</td>
        <td name="td2">46.4</td>
        <td name="td3">0.3</td>
        <td name="td4">Coagulation factor x</td>
      </tr>
      <tr>
        <td name="td1">2Y5G-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2JKH-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2XC4-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">3IIT-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2Y5F-A</td>
        <td name="td2">45.8</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2Y5H-A</td>
        <td name="td2">45.7</td>
        <td name="td3">0.4</td>
        <td name="td4">Activated factor xa heavy</td>
      </tr>
      <tr>
        <td name="td1">2EI8-A</td>
        <td name="td2">45.7</td>
        <td name="td3">0.4</td>
        <td name="td4">Coagulation factor x, heavy</td>
      </tr>
      <tr>
        <td name="td1">3TK5-A</td>
        <td name="td2">45.6</td>
        <td name="td3">0.4</td>
        <td name="td4">Factor x heavy chain</td>
      </tr>
	  </tbody>
  </table>

<br><br>

                 
<p class="header_boxx6" id="references">References</p>
                
<a id="ref1"></a><font><strong>[1] An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase.</strong></font><br />
Buddai, S. K., Layzer, J. M., Lu, G., Rusconi, C. P., Sullenger, B. A., Monroe, D. M., & Krishnaswamy, S.<br />
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820749/" target="_blank" style="color:#520049" >The Journal of biological chemistry, 285(8), 5212–5223. (2009)</a>
<br />
                
<a id="ref2"></a><font><strong>[2] Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.</strong></font><br />
Soule, E. E., Bompiani, K. M., Woodruff, R. S., & Sullenger, B. A.<br />
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753633/" target="_blank" style="color:#520049">Nucleic acid therapeutics, 26(1), 1–9. (2016)</a>
<br />
                
<a id="ref3"></a><font><strong>[3] Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.</strong></font><br />
Gunaratne, R., Kumar, S., Frederiksen, J. W., Stayrook, S., Lohrmann, J. L., Perry, K., Bompiani, K. M., Chabata, C. V., Thalji, N. K., Ho, M. D., Arepally, G., Camire, R. M., Krishnaswamy, S., & Sullenger, B. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/29863725/" target="_blank" style="color:#520049">Nature biotechnology, 36(7), 606–613. (2018)</a>
<br />
                
<a id="ref4"></a><font><strong>[4] Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19.</strong></font><br />
Chabata, C. V., Frederiksen, J. W., Olson, L. B., Naqvi, I. A., Hall, S. E., Gunaratne, R., Kraft, B. D., Que, L. G., Chen, L., & Sullenger, B. A.<br />
<a href="https://pubmed.ncbi.nlm.nih.gov/35021888/" target="_blank" style="color:#520049">Nucleic acid therapeutics, 32(3), 139–150. (2022)</a>
<br />